Compare WAY & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | NOVT |
|---|---|---|
| Founded | 1999 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.3B |
| IPO Year | 2023 | 1999 |
| Metric | WAY | NOVT |
|---|---|---|
| Price | $27.91 | $145.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 3 |
| Target Price | $34.09 | ★ $194.50 |
| AVG Volume (30 Days) | ★ 2.0M | 366.4K |
| Earning Date | 11-02-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 569.23 | N/A |
| EPS | 0.43 | ★ 0.82 |
| Revenue | ★ $1,099,278,000.00 | $521,290,000.00 |
| Revenue This Year | $17.00 | $15.57 |
| Revenue Next Year | $10.68 | $15.87 |
| P/E Ratio | ★ $65.63 | $184.32 |
| Revenue Growth | 16.50 | ★ 35.49 |
| 52 Week Low | $17.26 | $98.27 |
| 52 Week High | $37.71 | $176.38 |
| Indicator | WAY | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 52.76 |
| Support Level | $23.64 | $141.72 |
| Resistance Level | $29.25 | $151.41 |
| Average True Range (ATR) | 1.05 | 5.99 |
| MACD | -0.05 | 1.44 |
| Stochastic Oscillator | 59.45 | 65.93 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.